Announcements Trials
Browse Landscape

Phase

Phase 1 3Phase 1/2 1

Status

Completed 3Unknown 2Terminated 1

Sponsor Class

INDUSTRY 3

Study Type

Interventional 3

Sponsor

Cancer Type

Other solid neoplasm 2

Conditions

Advanced Malignant Solid Tumors 2Advanced Cancer 1

Interventions

Paclitaxel 292Gemcitabine 254Carboplatin 254Cisplatin 251Radiotherapy 219Cyclophosphamide 218Irinotecan 184pembrolizumab 181Docetaxel 174Bevacizumab 166Capecitabine 148Nivolumab 141Fluorouracil 132Dexamethasone 125Bortezomib 123Oxaliplatin 115Cytarabine 113Erlotinib Hydrochloride 112Temozolomide 110Sorafenib 110Doxorubicin 106Rituximab 105Leucovorin 105Etoposide 105Filgrastim 99Everolimus 97Lenalidomide 95Pemetrexed 90Ipilimumab 90fludarabine phosphate 84

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 1 × Completed × vorolanib × Clear all
NCT04328506 2021-11-26

Bioequivalency Study of CM082 Tablet in Healthy Volunteers

AnewPharma

Phase 1 Completed
96 enrolled
Other solid neoplasm

Advanced Malignant Solid Tumors

NCT04126668 2020-05-21

A Study to Investigate the Food Effect on the Pharmacokinetics of CM082 Tablet in Chinese Healthy Volunteers

AnewPharma

Phase 1 Completed
24 enrolled
Other solid neoplasm

Advanced Malignant Solid Tumors

NCT01863485 2019-07-05

Phase 1 Study of CM082 (X-82) Tablets in Advanced Cancer Patients in China

AnewPharma

Phase 1 Completed
44 enrolled

Advanced Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡